Long-term effectiveness of antimalarial drugs in rheumatic diseases (Q35547553)

8 August 2017

Long-term effectiveness of antimalarial drugs in rheumatic diseases (English)

1 reference

8 August 2017

0 references

Aviña-Zubieta JA

1

1 reference

8 August 2017

Galindo-Rodriguez G

2

1 reference

8 August 2017

Newman S

3

1 reference

8 August 2017

Suarez-Almazor ME

4

1 reference

8 August 2017

Russell AS

5

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 October 1998

1 reference

Annals of the Rheumatic Diseases

8 August 2017

1 reference

8 August 2017

57

1 reference

8 August 2017

10

1 reference

8 August 2017

582-587

1 reference

Comparison of effects of two antimalarial agents, hydroxychloroquine sulfate and chloroquine phosphate, in patients with rheumatoid arthitis.

8 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752486

Incidence of hydroxychloroquine retinopathy in 1,207 patients in a large multicenter outpatient practice

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752486

Ophthalmological monitoring of patients taking antimalarials: preferred practice patterns.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752486

Ophthalmological monitoring for hydroxychloroquine toxicity: a scientific review of available data

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752486

Variations and trends in the prescription of initial second line therapy for patients with rheumatoid arthritis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752486

Retinal toxicity in long term hydroxychloroquine treatment

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752486

Hydroxychloroquine, dosage parameters and retinopathy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752486

Incidence of myopathy in patients treated with antimalarials. A report of three cases and a review of the literature

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752486

Antimalarial drug induced decrease in creatinine clearance.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752486

Dose refinements in long-term therapy of rheumatoid arthritis with antimalarials

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752486

Comparison of hydroxychloroquine and chloroquine use and the development of retinal toxicity

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752486

Current practice in antimalarial drug prescribing in rheumatoid arthritis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752486

Antimalarials in rheumatology: efficacy and safety

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752486

Adjunctive use of hydroxychloroquine in childhood dermatomyositis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752486

Palindromic rheumatism: a response to chloroquine

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752486

The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis results of two metaanalyses

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752486

Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752486

Long-term second-line treatment: a prospective drug survival study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752486

Ophthalmologic safety of long-term hydroxychloroquine treatment

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752486

Psoriatic arthritis: A clinical, immunologic and HLA study of 100 patients

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752486

Further observations on the use of 4-aminoquinoline compounds in patients with rheumatoid arthritis or related diseases

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752486

Treatment of lupus erythematosus with mepacrine

26 September 2018

1 reference

12 December 2020

Are the results of controlled clinical trials and observational studies of second line therapy in rheumatoid arthritis valid and generalizable as measures of rheumatoid arthritis outcome: analysis of 122 studies

1 reference

12 December 2020

Analysis of treatment terminations with gold and antimalarial compounds in rheumatoid arthritis

1 reference

12 December 2020

Use of second line drugs for the treatment of rheumatoid arthritis in Edmonton, Alberta. Patterns of prescription and longterm effectiveness

1 reference

12 December 2020

Antimalarial workshop

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.57.10.582

1 reference

8 August 2017

1 reference

8 August 2017

1 reference